Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate
- PMID: 23513242
- PMCID: PMC3721050
- DOI: "V体育官网入口" 10.1148/radiol.13120816
VSports手机版 - Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate
Abstract
Purpose: To determine the prevalence of interstitial lung abnormalities (ILAs) at initial computed tomography (CT) examination and the rate of progression of ILAs on 2-year follow-up CT images in a National Lung Screening Trial population studied at a single site VSports手机版. .
Materials and methods: The study was approved by the institutional review board and informed consent was obtained from all participants. Image review for this study was HIPAA compliant. We reviewed the CT images of 884 cigarette smokers who underwent low-dose CT at a single site in the National Lung Screening Trial. CT findings were categorized as having no evidence of ILA, equivocal for ILA, or ILA. We categorized the type of ILA as nonfibrotic (ground-glass opacity, consolidation, mosaic attenuation), or fibrotic (ground glass with reticular pattern, reticular pattern, honeycombing). We evaluated the temporal change of the CT findings (no change, improvement, or progression) of ILA at 2-year follow-up. A χ(2) with Fisher exact test or unpaired t test was used to determine whether smoking parameters were associated with progression of ILA at 2-year follow-up CT. V体育安卓版.
Results: The prevalence of ILA was 9. 7% (86 of 884 participants; 95% confidence interval: 7. 9%, 11. 9%), with a further 11. 5% (102 of 884 participants) who had findings equivocal for ILA. The pattern was fibrotic in 19 (2. 1%), nonfibrotic in 52 (5. 9%), and mixed fibrotic and nonfibrotic in 15 (1. 7%) of the 86 participants with ILA. The percentage of current smokers (P = V体育ios版. 001) and mean number of cigarette pack-years (P = . 001) were significantly higher in those with ILA than those without. At 2-year follow-up of those with ILA (n = 79), findings of nonfibrotic ILA improved in 49% of cases and progressed in 11%. Fibrotic ILA improved in 0% and progressed in 37% of cases. .
Conclusion: ILA is common in cigarette smokers. Nonfibrotic ILA improved in about 50% of cases, and fibrotic ILA progressed in about 37%. VSports最新版本.
"V体育2025版" Figures






Comment in
-
Screening for lung cancer and idiopathic pulmonary fibrosis: killing two birds with one stone. (VSports在线直播)Radiology. 2014 Feb;270(2):630-1. doi: 10.1148/radiol.13131866. Radiology. 2014. PMID: 24471399 No abstract available.
-
Risk factors for development of acute lung injury, physicians' decision-making roles in critical illness, and prevalence of interstitial lung abnormalities in lung cancer screening populations.Am J Respir Crit Care Med. 2014 May 15;189(10):1273-4. doi: 10.1164/rccm.201401-0159RR. Am J Respir Crit Care Med. 2014. PMID: 24832744 Free PMC article. No abstract available.
References
-
- American Thoracic Society Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161(2 Pt 1):646–664 - PubMed
-
- American Thoracic Society; European Respiratory Society American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165(2):277–304 [Published correction appears in Am J Respir Crit Care Med 2002;166(3):426.] - PubMed
-
- Washko GR, Lynch DA, Matsuoka S, et al. Identification of early interstitial lung disease in smokers from the COPDGene Study. Acad Radiol 2010;17(1):48–53 - "V体育安卓版" PMC - PubMed
-
- Fernández Pérez ER, Daniels CE, Schroeder DR, et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest 2010;137(1):129–137 - "VSports注册入口" PMC - PubMed
Publication types
- "V体育官网入口" Actions
MeSH terms
- VSports最新版本 - Actions
- Actions (V体育ios版)
- "V体育2025版" Actions
- Actions (VSports在线直播)
- "VSports" Actions
- "VSports注册入口" Actions
- "V体育ios版" Actions
Grants and funding
LinkOut - more resources (VSports app下载)
Full Text Sources
Other Literature Sources
"VSports最新版本" Medical
Research Materials